CGON Stock: Price, Earnings History and SEC Filings
CG Oncology, Inc. (CGON) last traded at $64.68, up 1.91% on the latest session and down 8.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.90 against an analyst estimate of $-0.70, a miss of 28.6%.
$64.68 +1.91%
1 month-8.76%
52-week high$80.97
52-week low$35.80
Volume870,332
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CGON earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.90 | $-0.70 | -28.57% |
| Mar 2026 | May 8, 2026 | $-0.71 | $-0.58 | -22.41% |
| Dec 2025 | Feb 27, 2026 | $-0.51 | $-0.61 | +16.39% |
| Sep 2025 | Nov 14, 2025 | $-0.57 | $-0.57 | +0.00% |
CGON beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for CGON
SEC filing data is not available right now. You can search for CGON on SEC EDGAR.
CGON news
- CG Oncology: A Second-Mover Advantage In Bladder-Sparing TherapyOct 27, 2026 · seekingalpha.com
About CG Oncology, Inc.
CG Oncology, Inc. (CGON) is a US-listed public company on Nasdaq.